Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats
- 17 July 1995
- journal article
- Published by Elsevier in Brain Research
- Vol. 686 (1) , 37-43
- https://doi.org/10.1016/0006-8993(95)00448-y
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Increased Anticholinergic Sensitivity Following Closed Skull Impact and Controlled Cortical Impact Traumatic Brain Injury in the RatJournal of Neurotrauma, 1994
- Selective cognitive impairment following traumatic brain injury in ratsBehavioural Brain Research, 1993
- Characterization of BIBN 99: A lipophilic and selective muscarinic M2 receptor antagonistEuropean Journal of Pharmacology, 1993
- Muscarinic potentiation of excitatory amino acid‐evoked dopamine release in mesencephalic cells: Specificity for the NMDA response and role of intracellular messengersSynapse, 1993
- Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacologyLife Sciences, 1993
- Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injuryPharmacology Biochemistry and Behavior, 1990
- The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain InjuryScience, 1989
- A fluid percussion model of experimental brain injury in the ratJournal of Neurosurgery, 1987
- Return to work within the first seven years of severe head injuryBrain Injury, 1987
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982